Shanghai Conant Optical Co. Ltd. Class H
HHKEX:227635.46
HKD
-1.78
(-4.78%)
ISIN
CNE100004Z14
Return %
Stock
S&P 500
1Y
-9.40
14.20
3Y
491.00
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Zheng Xiang Fei
- Full Time Employees
- 2,890
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Bldg 35, No. 1-42 Ln 83Hongxiang N. Rd Shanghai SH China
- IPO Date
- Dec 16, 2021
- Website
- conantoptical.com.cn
- Similar Companies
- Business
- Shanghai Conant Optical Co., Ltd. manufactures and sells resin spectacle lenses principally in Mainland China, the Americas, Asia, Europe, Oceania and Africa. The company offers standardized and customized lenses, including UV++ series, 1.74 series, single vision, student, progressive, hi-vex, business, specialty and anti-fog lenses; UV shield and gaming glasses; Smart Vision myopia-reducing lenses; Polarized Night-vision lenses for nighttime driving safety; color-shift lenses; Smart Parabolic 6k Progressive lenses; CSD wear- and scratch-resistant lenses; photochromic lenses; polarized lenses; industrial safety lenses; and anti-reflective coatings. It operates production bases in Shanghai and Jiangsu in China and Sabae in Japan; serves spectacle lens brand owners and international ophthalmic optic companies; and provides after-sales support services. Founded in 1996 and headquartered at Building 35, No. 1-42 Lane 83, Hongxiang North Road, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone, Shanghai, China, the company listed H shares on the Hong Kong Stock Exchange in December 2021 under ticker 2276. In recent developments, Shanghai Conant Optical records revenue growth in its XR business segment through collaborations with leading global technology and consumer electronics enterprises, achieving approximately RMB10 million in aggregate revenue as of August 2025 from non-recurring engineering fees, trial orders and mass production; issues new H shares to Goertek (Hong Kong) Co., Limited in January 2025 raising net proceeds of approximately HK$827.9 million earmarked for research, development and manufacturing of lenses for smart glasses and XR headsets; advances construction of a Thailand production base and an automated customized lens production line at its Japanese subsidiary Asahi Optical with US$4 million investment; and launches employee share award schemes in 2023 and 2025 including repurchase of 15 million H shares for incentives.